Many factors influence quality of life for patients with irritable bowel syndrome

September 13, 2004

CHICAGO - The quality of life for patients with irritable bowel syndrome is as related to non-gastrointestinal (GI) symptoms, including tiring easily and feeling tense, as it is to GI symptoms associated with the disorder, according to an article in the September 13 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

Irritable bowel syndrome (IBS) is a chronic disorder of the gastrointestinal tract characterized by frequent abdominal pain and abnormal bowel habits. IBS affects 15 percent of the general adult population, results in 3.6 million physician visits annually, and costs more than $8 billion per year. Patients with IBS have worse health-related quality of life (HRQOL) than patients with diabetes or severe kidney disease, the article states. However, data suggest that many physicians do not adequately assess the impact of IBS symptoms and non-disease-related symptoms on their patients' lives and health status.

Brennan M. R. Spiegel, M.D., M.S.H.S., of The David Geffen School of Medicine at the University of California, Los Angeles, and colleagues identified several factors that play a role in the HRQOL in patients with IBS.

The researchers examined 770 patients, 18 years and older (69.1 percent female), with IBS at a university-based referral center. Participants completed a 90-item questionnaire on their symptoms, and a 36-item health survey.

The researchers found seven factors were related to patients' HRQOL: making more than five physician visits per year, tiring easily, low energy, severe symptoms, predominantly painful symptoms, feeling that there is "something seriously wrong with my body," and symptom flares lasting longer than 24 hours. The researchers found that eight factors were related to mental HRQOL: feeling tense, feeling nervous, feeling hopeless, difficulty sleeping, tiring easily, low sexual interest, IBS symptoms interfering with sexual function, and low energy.

"... we have identified specific clinical predictors of mental and physical HRQOL that may facilitate efficient assessment and targeted treatment in patients with IBS," the researchers write. "Whereas physical HRQOL is associated with symptom severity, symptom periodicity, and pain, mental HRQOL is associated with abnormalities in sexuality, mood, and anxiety."

"These findings suggest that rather than focusing on physiological epiphenomena (stool characteristics and subtype of IBS) and potentially misleading clinical factors (age and disease duration), physicians might be better served to gauge global symptom severity, address anxiety, and eliminate factors contributing to chronic stress in patients with IBS."
-end-
(Arch Intern Med. 2004;164:1773-1780. Available post-embargo at archinternmed.com) Editor's Note: This study was supported by a training grant (Dr. Spiegel), a Career Development Award (Drs. Dulai and Mayer), and a grant from the National Institutes of Health, Bethesda, Md., and by an Advanced Career Development Award from the VA HSR&D, Washington, DC (Dr. Gralnek).

For more information, contact JAMA/Archives Media Relations at 312-464-JAMA (5262) or e-mail mediarelations@jama-archives.org.

The JAMA Network Journals

Related Irritable Bowel Syndrome Articles from Brightsurf:

Giant spider provides promise of pain relief for irritable bowel syndrome
Molecules from the venom of one of the world's largest spiders could help University of Queensland-led researchers tailor pain blockers for people with irritable bowel syndrome (IBS).

An aspirin a day keeps the bowel doctor away
A regular dose of aspirin to reduce the risk of inherited bowel cancer lasts at least 10 years after stopping treatment, research has revealed.

Mindfulness program may benefit patients with irritable bowel syndrome
Adults with irritable bowel syndrome experienced fewer gastrointestinal symptoms after they participated in a mindfulness program meant to reduce stress.

The Lancet Gasteroenterology & Hepatology: First clinical trial finds probiotic treatment with dead bacteria is better than placebo at alleviating symptoms of irritable bowel syndrome
Probiotic bacteria that have been killed by heat can significantly improve symptoms of irritable bowel syndrome (IBS) compared to placebo, and are not associated with any safety risk, according to a new 12-week, randomized, double-blind, placebo-controlled clinical trial with 443 patients published in The Lancet Gastroenterology & Hepatology journal.

Are steroids used too much for patients with inflammatory bowel disease?
Steroid therapy is commonly used to treat acute attacks of the inflammatory bowel diseases ulcerative colitis and Crohn's disease; however, because it does not provide long-term benefits and it carries a risk of serious side effects, it should not be used to treat inflammatory bowel disease for more than three months.

New, noninvasive test for bowel diseases
Gut diseases such as inflammatory bowel disease (IBD) are increasingly prevalent worldwide, especially in industrialized countries.

HKBU discovers mechanisms underlying early life stress and irritable bowel syndrome
Researchers from Hong Kong Baptist University have found that the abnormal rise of a soluble protein called Nerve Growth Factor is a key factor linking early life stress to the development of irritable bowel syndrome.

Microbiome science may help doctors deliver more effective, personalized treatment to children with irritable bowel syndrome
To improve the treatment of children with irritable bowel syndrome (IBS), investigators have developed a sophisticated way to analyze the microbial and metabolic contents of the gut.

The Lancet Gastroenterology & Hepatology: Hypnotherapy could help relieve irritable bowel syndrome symptoms
Peer-reviewed / Randomised Controlled Trial / People Gut-directed hypnotherapy delivered by psychologists appears as effective in group or individual sessions, potentially offering a new treatment option for irritable bowel syndrome in primary and secondary care

Early source of irritable bowel syndrome discovered
Michigan State University scientists have identified an early cause of intestinal inflammation, one of the first stages of inflammatory bowel disease and irritable bowel syndrome, which afflict around 11 percent of the world's population.

Read More: Irritable Bowel Syndrome News and Irritable Bowel Syndrome Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.